Daniel A Vallera

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model.

Rose H Dicovitsky, Jill T Schappa, Ashley J Schulte

|Dec 22, 2022
Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings.

Jacob Petersburg, Daniel A Vallera, Carston R Wagner

|Aug 27, 2021
A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer.

Daniel A Vallera, Felix Oh, Behiye Kodal

|Sep 23, 2020
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo.

Daniel A Vallera, Soldano Ferrone, Behiye Kodal

|Jul 08, 2020
Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors.

Felix Oh, Jaime F Modiano, Veronika Bachanova

|Jan 01, 2020
Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization.

Cathrine Elisabeth Olsen, Lawrence H Cheung, Anette Weyergang

Pageof 2

Frequent Collaborators

2 joint publications

Felix Oh

2 joint publications

Jaime F Modiano

1 joint publications

Martin Felices

1 joint publications

Jeffrey S Miller